Extendicare (TSE:EXE) Price Target Cut to C$39.00 by Analysts at Desjardins

Extendicare (TSE:EXE) had its price target lowered by analysts at Desjardins from C$40.00 to C$39.00 in a research note issued to investors on Monday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Desjardins’ price objective points to a potential upside of 21.16% from the stock’s previous close.

EXE has been the subject of several other research reports. BMO Capital Markets upped their price target on Extendicare from C$30.00 to C$38.00 in a report on Wednesday, May 13th. TD lifted their price objective on Extendicare from C$32.00 to C$39.00 and gave the stock a “buy” rating in a report on Monday, May 11th. National Bank Financial boosted their price objective on Extendicare from C$34.00 to C$40.00 and gave the company an “outperform” rating in a research report on Wednesday, May 27th. Finally, Canaccord Genuity Group upgraded Extendicare to a “strong-buy” rating in a research note on Monday, May 11th. One analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average price target of C$35.44.

Extendicare Stock Performance

Extendicare stock traded down C$0.25 during mid-day trading on Monday, reaching C$32.19. The company had a trading volume of 363,614 shares, compared to its average volume of 388,127. The company has a quick ratio of 0.98, a current ratio of 1.44 and a debt-to-equity ratio of 82.55. The firm has a market cap of C$3.05 billion, a price-to-earnings ratio of 23.69 and a beta of 1.59. The company has a 50 day moving average of C$35.24 and a 200-day moving average of C$30.25. Extendicare has a 52 week low of C$12.64 and a 52 week high of C$39.14.

Extendicare (TSE:EXE) last posted its quarterly earnings data on Thursday, August 6th. The company reported C$0.32 earnings per share (EPS) for the quarter. Extendicare had a net margin of 6.99% and a return on equity of 45.35%. The company had revenue of C$611.04 million for the quarter. On average, sell-side analysts expect that Extendicare will post 0.6134729 EPS for the current fiscal year.

About Extendicare

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.